Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells)

G. Zauli, M. C. Re, G. Furlini, M. Giovannini, M. La Placa

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The effects of human immunodeficiency virus type 1 (HIV-1) and recombinant envelope glycoprotein gp120 on the in vitro growth of enriched human haematopoietic progenitors (CD34+ cells) have been investigated. A 2 h exposure to HIV-1 resulted in a progressive and significant reduction of viable CD34+ cell number in liquid cultures and of granulocyte-macrophage, erythroid and megakaryocytic progenitors in semisolid cultures. In virus-treated CD34+ cells, no signs of active virus replication were observed and the possibility of latent infection was excluded by quantitative polymerase chain reaction. Recombinant HIV-1 envelope glycoprotein gp120 added to CD34+ cell cultures displayed a dose-dependent inhibitory activity on CD34+ cell viability. Neutralizing antibody against gp120 was able to block completely the inhibitory activity on CD34+ cells of either HIV-1 or recombinant gp120. These results demonstrate that HIV-1 envelope glycoprotein gp120 has a direct cytotoxic effect on CD34+ cells.

Original languageEnglish
Pages (from-to)417-421
Number of pages5
JournalJournal of General Virology
Volume73
Issue number2
Publication statusPublished - 1992

Fingerprint

Hematopoietic Stem Cells
HIV-1
Glycoproteins
Virus Replication
Neutralizing Antibodies
Granulocytes
Cell Survival
Cell Culture Techniques
Cell Count
Macrophages
Viruses
Polymerase Chain Reaction
Growth
Infection

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). / Zauli, G.; Re, M. C.; Furlini, G.; Giovannini, M.; La Placa, M.

In: Journal of General Virology, Vol. 73, No. 2, 1992, p. 417-421.

Research output: Contribution to journalArticle

Zauli, G. ; Re, M. C. ; Furlini, G. ; Giovannini, M. ; La Placa, M. / Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). In: Journal of General Virology. 1992 ; Vol. 73, No. 2. pp. 417-421.
@article{611ec0555ff64464b49962036ce0b83e,
title = "Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells)",
abstract = "The effects of human immunodeficiency virus type 1 (HIV-1) and recombinant envelope glycoprotein gp120 on the in vitro growth of enriched human haematopoietic progenitors (CD34+ cells) have been investigated. A 2 h exposure to HIV-1 resulted in a progressive and significant reduction of viable CD34+ cell number in liquid cultures and of granulocyte-macrophage, erythroid and megakaryocytic progenitors in semisolid cultures. In virus-treated CD34+ cells, no signs of active virus replication were observed and the possibility of latent infection was excluded by quantitative polymerase chain reaction. Recombinant HIV-1 envelope glycoprotein gp120 added to CD34+ cell cultures displayed a dose-dependent inhibitory activity on CD34+ cell viability. Neutralizing antibody against gp120 was able to block completely the inhibitory activity on CD34+ cells of either HIV-1 or recombinant gp120. These results demonstrate that HIV-1 envelope glycoprotein gp120 has a direct cytotoxic effect on CD34+ cells.",
author = "G. Zauli and Re, {M. C.} and G. Furlini and M. Giovannini and {La Placa}, M.",
year = "1992",
language = "English",
volume = "73",
pages = "417--421",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",
number = "2",

}

TY - JOUR

T1 - Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells)

AU - Zauli, G.

AU - Re, M. C.

AU - Furlini, G.

AU - Giovannini, M.

AU - La Placa, M.

PY - 1992

Y1 - 1992

N2 - The effects of human immunodeficiency virus type 1 (HIV-1) and recombinant envelope glycoprotein gp120 on the in vitro growth of enriched human haematopoietic progenitors (CD34+ cells) have been investigated. A 2 h exposure to HIV-1 resulted in a progressive and significant reduction of viable CD34+ cell number in liquid cultures and of granulocyte-macrophage, erythroid and megakaryocytic progenitors in semisolid cultures. In virus-treated CD34+ cells, no signs of active virus replication were observed and the possibility of latent infection was excluded by quantitative polymerase chain reaction. Recombinant HIV-1 envelope glycoprotein gp120 added to CD34+ cell cultures displayed a dose-dependent inhibitory activity on CD34+ cell viability. Neutralizing antibody against gp120 was able to block completely the inhibitory activity on CD34+ cells of either HIV-1 or recombinant gp120. These results demonstrate that HIV-1 envelope glycoprotein gp120 has a direct cytotoxic effect on CD34+ cells.

AB - The effects of human immunodeficiency virus type 1 (HIV-1) and recombinant envelope glycoprotein gp120 on the in vitro growth of enriched human haematopoietic progenitors (CD34+ cells) have been investigated. A 2 h exposure to HIV-1 resulted in a progressive and significant reduction of viable CD34+ cell number in liquid cultures and of granulocyte-macrophage, erythroid and megakaryocytic progenitors in semisolid cultures. In virus-treated CD34+ cells, no signs of active virus replication were observed and the possibility of latent infection was excluded by quantitative polymerase chain reaction. Recombinant HIV-1 envelope glycoprotein gp120 added to CD34+ cell cultures displayed a dose-dependent inhibitory activity on CD34+ cell viability. Neutralizing antibody against gp120 was able to block completely the inhibitory activity on CD34+ cells of either HIV-1 or recombinant gp120. These results demonstrate that HIV-1 envelope glycoprotein gp120 has a direct cytotoxic effect on CD34+ cells.

UR - http://www.scopus.com/inward/record.url?scp=0026515955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026515955&partnerID=8YFLogxK

M3 - Article

C2 - 1371543

AN - SCOPUS:0026515955

VL - 73

SP - 417

EP - 421

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

IS - 2

ER -